Usage of potent CYP1A2 inhibitors must be discontinued in advance of initiating pirfenidone and averted in the course of treatment; if powerful CYP1A2 inhibitors are the sole drug of alternative, dosage reductions are recommended Extra checking and dosage adjustment could be desired in accordance with solution labeling of CYP1A2 substrates. https://theaflavin22109.diowebhost.com/84814880/a-review-of-phosphatase-inhibitor-cocktail-ii-100-dmso